Get the Stockscreener App
2.59
0.00%
-0.0001
After Hours:
2.59
Neuraxis Inc stock is traded at $2.59, with a volume of 46,695.
It is down -0.00% in the last 24 hours and down -11.30% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$2.5901
Open:
$2.34
24h Volume:
46,695
Relative Volume:
6.24
Market Cap:
$16.89M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-3.211
EPS:
-0.8066
Net Cash Flow:
-
1W Performance:
-11.30%
1M Performance:
-11.30%
6M Performance:
-19.31%
1Y Performance:
+3.60%
1-Day Range:
$2.14
$2.70
1-Week Range:
$2.05
$2.88
52-Week Range:
$2.00
$3.89
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Neuraxis Inc Stock (NRXS) Latest News
Southside Bancshares, Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange - The Manila Times
NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market - GlobeNewswire
IRIDEX (NASDAQ:IRIX) versus NeurAxis (NASDAQ:NRXS) Financial Survey - Defense World
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 - The Manila Times
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewswire
Neuraxis adjusts equity agreement, secures additional funding - Investing.com India
Creatd (NASDAQ:VOCL) Stock Price Down 4.4% – Should You Sell? - Defense World
Technip Energies (OTCMKTS:THNPY) Trading Up 0.7% – Here’s What Happened - Defense World
Vestas Wind Systems A/S (OTCMKTS:VWSYF) Shares Up 1.2% – Here’s What Happened - Defense World
Zacks Initiates Coverage of NeurAxis With Neutral Recommendation - Yahoo Finance
The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis - Yahoo Finance
Top Analyst Reports for Costco Wholesale, Alibaba & GE Aerospace - Yahoo Finance
NeurAxis (NASDAQ:NRXS) Trading Up 6% - Defense World
NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewswire
Neuraxis issues shares in equity financing By Investing.com - Investing.com Australia
Neuraxis issues shares in equity financing - Investing.com
Fishers startup prepares to go public - Greenfield Daily Reporter
NeurAxis (NASDAQ:NRXS) Stock Price Down 2.2% - Defense World
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewswire
Vagus Nerve Stimulators Market Projected to Witness Huge Growth - openPR
Neuraxis shareholders approve key proposals at annual meeting - Investing.com
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewswire
NeurAxis revenue down 5.3% to USD 611.5K in Q2 2024 - Medical Buyer
NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha
Contrasting Sonova (OTCMKTS:SONVY) & NeurAxis (NASDAQ:NRXS) - Defense World
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 - MSN
NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewswire
NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Vagus Nerve Stimulators Market Is Booming Worldwide 2024-2031 | - openPR
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 - GlobeNewswire
NeurAxis Gains $3 Million In Financing - MPO-mag
Head to Head Comparison: NeurAxis (NASDAQ:NRXS) vs. Positron (OTCMKTS:POSC) - Defense World
Vagus Nerve Stimulators Market Expected to Expand at a Steady - openPR
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - Marketscreener.com
ZUU Co. Ltd. executives purchase Pono Capital two shares worth $390 By Investing.com - Investing.com India
Neuraxis issues stock awards to non-employee directors - Investing.com
Blackstone director Baratta sells over $14 million in company stock By Investing.com - Investing.com UK
Head to Head Survey: NeurAxis (NASDAQ:NRXS) versus Electromed (NYSE:ELMD) - Defense World
NeurAxis (NASDAQ:NRXS) and Cutera (NASDAQ:CUTR) Head-To-Head Analysis - Defense World
NRXSNeurAxis, Inc. Latest Stock News & Market Updates - StockTitan
NeurAxis (NASDAQ:NRXS) Stock Price Down 3.3% - Defense World
Nexalin Technology (NASDAQ:NXL) & NeurAxis (NASDAQ:NRXS) Financial Review - Defense World
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with ... - GlobeNewswire
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - GlobeNewswire Inc.
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - Yahoo Finance
Outset Medical (NASDAQ:OM) & NeurAxis (NASDAQ:NRXS) Head-To-Head Analysis - Defense World
Vagus Nerve Stimulators Market to Surpass US$ 1,158.7 Mn by 2031 with CAGR 9.7% - WhaTech
NeurAxis Reports First Quarter 2024 Financial Results - br.ADVFN.com
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store? - MSN
Reviewing NeurAxis (NASDAQ:NRXS) and Outset Medical (NASDAQ:OM) - Defense World
NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript - Seeking Alpha
Neuraxis Inc Stock (NRXS) Financials Data
There is no financial data for Neuraxis Inc (NRXS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.11%
0.50%
Cap:
|
Volume (24h):